TBPH

Theravance Biopharma Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Value↑ 5/10
Theravance Biopharma sales and earnings growth
TBPH Growth
Great
  • Revenue Y/Y↑ 61.59%
  • EPS Y/Y↑ 292.37%
  • FCF Y/Y↑ 732.40%
Theravance Biopharma gross and profit margin trends
TBPH Profitability
Great
  • Gross margin ↑ 100.00%
  • EPS margin↑ 104.30%
  • ROIC 5Y↑ 32.07%
Theravance Biopharma net debt vs free cash flow
TBPH Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 76.3

Theravance Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks